Newsletter Archive

31. 04.20.21 -- Overcoming Obstacles For Viral Vector Downstream Manufacturing 4/20/2021
    04/20/21 BioProcess Online Newsletter
32. 04.19.21 -- Make Buffer Management And Chromatography Your Competitive Advantages 4/19/2021
    04/19/21 BioProcess Online Newsletter
33. 04.19.21 -- 5 FDA Regulatory Science, Approval Trends 4/19/2021
    04/19/21 BioProcess Online Newsletter
34. 04.15.21 -- Generating A Fully Processed Antibody 4/15/2021
    04/15/21 BioProcess Online Newsletter
35. 04.14.21 -- How To Commercially Scale T-Cell Allogeneic Therapies 4/14/2021
    04/14/21 BioProcess Online Newsletter
36. 04.14.21 -- Your Drug Development Team Holds The Key To The Clinic 4/14/2021

    04/14/21 BioProcess Online Newsletter

37. 04.13.21 -- A Systematic Approach To Early Phase Sterile Tech Transfer 4/13/2021
    04/13/21 BioProcess Online Newsletter
38. 04.13.21 -- Cell & Gene Therapy Process Development Resources 4/13/2021
    04/13/21 BioProcess Online Newsletter
39. 04.12.21 -- Accelerate Viral Detection From Weeks To Days 4/12/2021
    04/12/21 BioProcess Online Newsletter
40. 04.12.21 -- Medicare Braces For Expanded Use Of High-Cost CAR T-Cell Therapy 4/12/2021

    04/12/21 BioProcess Online Newsletter